Views & Analysis Fast-track appraisals and Managed Access Agreements Experts discuss England’s proposed ‘fast-track’ appraisals for new treatments, plus MAAs.
Views & Analysis High-value, high-cost drugs: how to pay for them Experts call for urgent development of new drug funding mechanisms.
Views & Analysis Digital Health Round-up: Fitbit falters, NHS picks six winne... A round-up of this week’s top digital healthcare news. Marco Ricci reports.
News Mental health the focus of new £400K NHS England digital fun... Six to eight innovations will be chosen to take part in the Digital Development Lab.
Views & Analysis NICE and NHS England unveil ‘fast-track’ and affordability s... NHS England will be able to control cost impact of NICE decisions more directly.
News NHS to adopt Healthera's digital medicines adherence tools App, pharmacy suite and analytics platform could improve medication adherence.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.